Gary Sender

CIK 1659085 · Chief Financial Officer · last filed 2026-05-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$264.8K

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$1.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HRMY Director $34.46 $0 7 2026-05-18
IBIO Director 9,191 $1.69 $15.5K $25.0K 5 2025-11-24
SDGR Director 17,247 $14.45 $249.2K -$1.91M 7 2025-06-20
Nabriva Therapeutics plc (NBRV) Delisted Chief Financial Officer 20,472 $1.42 $29.1K $18.5K 23 2021-03-02

Recent Filings · Page 2 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-16 SDGR Grant (A) $0 EDGAR
2022-05-24 HRMY Grant (A) $0 EDGAR
2021-12-13 IBIO Grant (A) $0 EDGAR
2021-06-21 SDGR Grant (A) $0 EDGAR
2021-06-14 HRMY Grant (A) $0 EDGAR
2021-03-10 SDGR Mixed -$1.61M EDGAR
2021-03-02 Nabriva Therapeutics plc (NBRV) Delisted Tax (F) −31 -$74 EDGAR
2021-02-02 Nabriva Therapeutics plc (NBRV) Delisted Tax (F) −37 -$97 EDGAR
2021-01-05 Nabriva Therapeutics plc (NBRV) Delisted Tax (F) −32 -$77 EDGAR
2020-12-01 Nabriva Therapeutics plc (NBRV) Delisted Tax (F) −312 -$133 EDGAR
Showing 1120 of 43
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.